Novo Nordisk | NVO - Stock


Novo Nordisk reported DKK51.35B in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
ANI Pharmaceuticals USD 143.15M 319K Jun/2026
Aurora Cannabis CAD 175.08M 55.48M Mar/2026
Bausch Health Companies USD 1.6B 1000K Jun/2026
Bristol-Myers Squibb USD 2.74B 19M Jun/2026
Canopy Growth CAD 110.51M 4.96M Mar/2026
Corcept Therapeutics USD 13.18M 295K Jun/2026
Drreddys Laboratories INR 76.53B 2.48B Mar/2026
Eli Lilly USD 16.79B 2.26B Jun/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Merck USD 6.21B 272M Jun/2026
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novartis USD 6.22B 66M Jun/2026
Novo Nordisk DKK 45.65B 21.26B Jun/2025
Novo Nordisk DKK 51.35B 8.5B Mar/2026
Pacira USD 134.57M 15.8M Jun/2026
Perrigo USD 1.06B 56.9M Jun/2026
Phibro Animal Health USD 539.7M 22.35M Mar/2026
Prestige Brands USD 190.22M 31.08M Jun/2026
Sanofi EUR 24.12B 620M Jun/2026
Supernus Pharmaceuticals USD 107.03M 3.74M Jun/2026
Zoetis USD 2.57B 24M Jun/2026